InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

OSR Health, Inc.

OSRH Clue Score28
United States Fiscal year ends December CIK 0001840425
$0.20 -7.14% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.20 −98.13% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Mar 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Operating income−0.0Net income−0.0Fiscal year 2022Operating income−0.0Net income−0.0EPS, diluted−0.01Fiscal year 2023Operating income−1.8Net income0.4EPS, diluted0.05Fiscal year 2024Revenue3.5Operating income−11.7Net income−2.4 −697.1%EPS, diluted−4.79Fiscal year 2025Revenue2.9 −17.7%Operating income−18.3Net income−27.1EPS, diluted−0.80
FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a 3.5 2.9
Growth −17.7%
Operating income −0.0 −0.0 −1.8 −11.7 −18.3
Net income −0.0 −0.0 0.4 −2.4 −27.1
Growth −697.1%
EPS, diluted n/a −0.01 0.05 −4.79 −0.80

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Gross margin23.0%Operating margin−331.2%Net margin−68.3%Fiscal year 2025Gross margin20.4%Operating margin−631.0%Net margin−931.2%
FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a 23.0% 20.4%
Operating margin n/a n/a n/a −331.2% −631.0%
Net margin n/a n/a n/a −68.3% −931.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2021Operating cash flow−0.0Fiscal year 2022Operating cash flow−0.0Fiscal year 2023Operating cash flow−0.8Buybacks−36.0Fiscal year 2024Operating cash flow−1.8Buybacks−36.2Fiscal year 2025Operating cash flow−4.3
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.0 −0.0 −0.8 −1.8 −4.3
Buybacks n/a n/a −36.0 −36.2 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash0.0Shareholders’ equity−0.0Fiscal year 2022Cash0.1Shareholders’ equity−0.0Fiscal year 2023Cash0.0Shareholders’ equity−3.9Fiscal year 2024Cash0.3Total debt0.5Net cash (debt)−0.2Shareholders’ equity−8.3Fiscal year 2025Cash1.7Shareholders’ equity127.0
FY2021FY2022FY2023FY2024FY2025
Cash 0.0 0.1 0.0 0.3 1.7
Total debt n/a n/a n/a 0.5 n/a
Net cash (debt) n/a n/a n/a −0.2 n/a
Shareholders’ equity −0.0 −0.0 −3.9 −8.3 127.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−0.0 −0.0 −0.8 −1.8 −4.3
Growth
Investment
n/a n/a −33.8 0.5 −2.6
Financing
−0.1 0.1 34.5 1.2 8.4
n/a n/a −36.0 −36.2 n/a

Capital expenditure, dividends and buybacks are shown as money out, so negative.